31 Amendments of Konrad SZYMAŃSKI related to 2011/0401(COD)
Amendment 240 #
Proposal for a regulation
Recital 5 a (new)
Recital 5 a (new)
(5a) In its Resolution of 11 November 2010, the European Parliament has also expressed its reservation to the abolishing of the legal requirement for an opinion by committees of representatives of Member States on the selection of projects with impact on ethics, security and defence.
Amendment 296 #
Proposal for a regulation
Recital 23
Recital 23
(23) The activities developed under Horizon 2020 should aim at promoting equality between men and women in research and innovation, by addressing in particular thHorizon 2020 funded research activities should comply with the Union acquis communautaire with regard to equal opportunities between men and women. Horizon 2020 should pay attention to excellent science uanderlying causes of gender imbalance, by exploiting the full potential of both female and male researchers, and by integrating the gender dimension into the content of projects in order to improve the quality of to professional qualification of scientific and research personal of both sexes involved in research and stimulate innovation. Activities should also aim at the implementation of the principles relating to the equality between women and men as laid down in Articles 2 and 3In order to assure the effective use of Union funding, the principal distinction for Union research funding should be the excellence of science project and the professional qualification of the Treaty on European Union and Article 8 TFEUsearch staff.
Amendment 300 #
Proposal for a regulation
Recital 23
Recital 23
(23) The activities developed under Horizon 2020 should aim at promoting equality between men and women in research and innovation, by addressing in particular the underlying causes of gender imbalance, by exploiting the full potential of both female and male researchers, and by integrating the gender dimension into the content of projects in order to improve the quality of research and stimulate innovation. Activities should also aim at the implementation of the principles relating to the equality between women and men as laid down in Articles 2 and 3 of the Treaty on European Union and Article 8 TFEU.
Amendment 309 #
Proposal for a regulation
Recital 24
Recital 24
(24) Research and innovation activities supported by Horizon 2020 should respect fundamental ethical principles. The opinions of the European Group on Ethics in Science and New Technologies should be taken into account. Research activities should also take into account Article 13 TFEU and reduce the use of animals in research and testing, with a view ultimately to replacing animal use. Horizon 2020 funding of research activities should respect the legislative provisions and customs of the Member States. All activities should be carried out ensuring a high level of human health protection in accordance with Article 168 TFEU.
Amendment 318 #
Proposal for a regulation
Recital 25
Recital 25
(25) The European Commission does not explicitly solicit the use of human embryonic stem cells. The use of human stem cells, be they adult or embryonic, if any, depends on the judgement of the scientists in view of the objectives they want to achievAttention should be paid to the considerable differences between national legislations of Member States with regard to research using human embryos and human embryonic stem cells. Union research policy should not lead to harmonise national legislation of Member States. The Commission should remember its statement, with regard to the Seventh Framework Programme, to continue the current practice and isnot subjecmit to stringent Ethics Review. No project involving the use of human embryonic stem cells should be funded that does not obtain the necessary approvals from the Member States. No activity should be funded that is forbidden in all Member States. No activity should be funded in a Member State where such activity is forbidden.the Regulatory Committee proposals for projects which include research activities which destroy human embryos, including for the procurement of stem cells1. This commitment should be included in this Regulation in order to ensure legal continuity. __________________ 1 Point 12 of the Commission statement regarding Article 6 annexed to Decision 1982/2006/EC of the European parliament and of the Council of 18 December 2006 concerning the 7th FRP of the EC for research, technological development and demonstration activities, OJ L 412, 30.12.2006, p.1
Amendment 329 #
Proposal for a regulation
Recital 25 a (new)
Recital 25 a (new)
(25a) The European Court of Justice has ruled in case C-34/101 that Union law precludes human embryonic stem cells from being patented. In accordance with that ruling, embryonic stem cell research should be excluded of Union funding. __________________ 1 Case C-34/10, Judgment of the Court (Grand Chamber) of 18 October 2011, Oliver Brüstle c. Greenpeace.
Amendment 334 #
Proposal for a regulation
Recital 25 b (new)
Recital 25 b (new)
(25b) Union research policy and research funding should ensure that scientist whose research is funded by the Union tax payers' money also patent their inventions in the Union. As human embryonic stem cells are not patentable (cf ECJ case law C-34/10), this type of research should be excluded from Union funding to ensure a responsible use of tax payers money. Nevertheless, a Member State can decide to fund this research exclusively by its national budget and in accordance to its national legislation.
Amendment 337 #
Proposal for a regulation
Recital 25 c (new)
Recital 25 c (new)
(25c) Research on alternative non- embryonic sources of stem cells that have proven more promising and less controversial should be strongly supported. Such incentive will also reinforce the competitiveness of the Union in such field.
Amendment 493 #
Proposal for a regulation
Article 13 – paragraph 1
Article 13 – paragraph 1
1. Linkages and interfaces shall be implemented across and within the priorities of Horizon 2020. Particular attention shall be paid in this respect to the development and application of key enabling and industrial technologies, to bridging from discovery to market application, to cross-disciplinary research and innovation, to social and economic sciences and humanities, to fostering the functioning and achievement of the ERA, to the development of research into European legal systems, to cooperation with third countries, to ethical responsible research and innovation including gender, andthe respect of equal opportunities between men and women in research, to enhancing the attractiveness of the research profession for both sexes and to facilitating cross- border and cross- sector mobility of researchers.
Amendment 494 #
Proposal for a regulation
Article 13 – paragraph 1
Article 13 – paragraph 1
1. Linkages and interfaces shall be implemented across and within the priorities of Horizon 2020. Particular attention shall be paid in this respect to the development and application of key enabling and industrial technologies, to bridging from discovery to market application, to cross-disciplinary research and innovation, to social and economic sciences and humanities, to fostering the functioning and achievement of the ERA, to cooperation with third countries, to responsible research and innovation including gender, and to enhancing the attractiveness of the research profession and to facilitating cross-border and cross- sector mobility of researchers.
Amendment 513 #
Proposal for a regulation
Article 15 – title
Article 15 – title
Amendment 516 #
Proposal for a regulation
Article 15 – paragraph 1
Article 15 – paragraph 1
Horizon 2020 shall ensure the effective promotion of gender equality and the gender dimensiorespect scientific excellence and professional qualification of research professionals when promoting equal opportunities for men and women in research and innovation content.
Amendment 519 #
Proposal for a regulation
Article 15 – paragraph 1
Article 15 – paragraph 1
Horizon 2020 shall ensure the effective promotion of gender equality and the gender dimension in research and innovation contbetween men and woment.
Amendment 537 #
Proposal for a regulation
Article 16 – paragraph 1 – subparagraph 1
Article 16 – paragraph 1 – subparagraph 1
All the research and innovation activities carried out under Horizon 2020 shall comply with ethical principles and relevant national, Union and international legislation, including the Charter of Fundamental Rights of the European Union and the European Convention on Human Rights and its Supplementary Protocols. , the Helsinki Declaration, the Convention of the Council of Europe on Human Rights and Biomedicine signed in Oviedo on 4 April 1997 and its Additional Protocols, the European Convention on Human Rights and its Supplementary Protocols, the UN resolution on human cloning of March 2005, the UN Convention on the Rights of the Child, the Universal Declaration on the human genome and human rights adopted by the UNESCO, the UN Biological and Toxin Weapons Convention (BTWC), the International Treaty on Plant Genetic Resources for Food and Agriculture and the relevant World Health Organisation's resolutions. Those carrying out or participating in research projects concerning ethical sensitive issues like for example DNA, analysis on humans, research on persons not able to give informed consent, research linked to the suffering of vertebrate animals etc. shall seek the approval of the relevant national or local ethics committee prior to the start of the activities. An ethical review will also be implemented systematically by the Commission. In specific cases an ethical review may take place during the implementation of a project. On a yearly basis, the Commission shall inform the European Parliament about their activities in this area, and in addition to this, it shall provide the European Parliament and the Council, with information upon request. During the implementation of this programme, scientific advances and national and international provisions shall be regularly monitored by the Commission so as to take account of any developments.
Amendment 550 #
Proposal for a regulation
Article 16 – paragraph 3 – point a
Article 16 – paragraph 3 – point a
(a) research activity aiming at human cloning for reproductive, therapeutic or scientific purposes;
Amendment 553 #
Proposal for a regulation
Article 16 – paragraph 3 – point b
Article 16 – paragraph 3 – point b
(b) research activity intended to modify the human genome for purposes other than preventive, diagnostic or therapeutic; as well as research activity intended to modify the genetic heritage of human beings which could make such changes heritable;
Amendment 557 #
Proposal for a regulation
Article 16 – paragraph 3 – point c
Article 16 – paragraph 3 – point c
(c) research activities intended either to create human embryos solely for the purpose of research or– by means of somatic cell nuclear transfer or by parthenogenesis or any other means – or to destroy human embryos for theany purpose, including that of stem cells procurement, including by means of somatic cell nuclear transfer; as well as any research activities involving the use of human embryonic stem cells.
Amendment 560 #
Proposal for a regulation
Article 16 – paragraph 3 – point c a (new)
Article 16 – paragraph 3 – point c a (new)
(c a) research involving the destruction of human embryos;
Amendment 580 #
Proposal for a regulation
Article 16 – paragraph 4
Article 16 – paragraph 4
4. Research on other types of human stem cells, both adult and embryonic, may be financed, depending both on the contents of the scientific proposal and the legal framework of the Member States involved. No funding shall be granted for research activities that are prohibited in all the Member States. No activity shall be funded in a Member State where such activity is forbidden.
Amendment 1138 #
Proposal for a regulation
Annex 1 – Part 2 – point 1 – point 1.4 – point 1.4.3 – point c – paragraph 1
Annex 1 – Part 2 – point 1 – point 1.4 – point 1.4.3 – point c – paragraph 1
Development of platform technologies (e.g. genomics, meta-genomics, proteomics, molecular tools) to enhance leadership and competitive advantage in a wide number of economic sectors. Diagnostic tools will be supported if there is a link to therapy.
Amendment 1142 #
Proposal for a regulation
Annex 1 – Part 2 – point 1 – point 1.4 – point 1.4.3 – point c a (new)
Annex 1 – Part 2 – point 1 – point 1.4 – point 1.4.3 – point c a (new)
(c a) Developing the societal dimension of biotechnology. Focusing on governance of biotechnology for societal benefits including ethical limits.
Amendment 1293 #
Proposal for a regulation
Annex 1 – Part 3 – point 1 – point 1.1 – paragraph 5 – subparagraph 1 (new)
Annex 1 – Part 3 – point 1 – point 1.1 – paragraph 5 – subparagraph 1 (new)
Rare diseases remain major challenge to the EU and the member states. There are 6000 to 8000 rare diseases affecting approx. 30 Million people across Europe. An effective treatment can only be developed if member states cooperate because the cases in any given member state are not enough to do effective research.
Amendment 1295 #
Proposal for a regulation
Annex 1 – Part 3 – point 1 – point 1.1 – paragraph 5 a (new)
Annex 1 – Part 3 – point 1 – point 1.1 – paragraph 5 a (new)
Diseases in children, including premature born children. Health of children is a core priority for the European Union. Similar to rare diseases effective research and treatment can only be developed in a common European effort.
Amendment 1356 #
Proposal for a regulation
Annex 1 – Part 3 – point 1 – point 1.3 – paragraph 5
Annex 1 – Part 3 – point 1 – point 1.3 – paragraph 5
Specific activities shall include: understanding the determinants of health (including environmental and climate related factors), improving health promotion and disease prevention; understanding disease and improving diagnosis; developing effective screening programmes and improving the assessment of disease susceptibility; improving surveillance and preparedness; developing better preventive vaccines; using in-silico medicine for improving disease management and prediction; treating disease; transferring knowledge to clinical practice and scalable innovation actions; better use of health data; active ageing, independent and assisted living; improving palliative medicine, individual empowerment for self-management of health; promotion of integrated care; improving scientific tools and methods to support policy making and regulatory needs; and optimising the efficiency and effectiveness of healthcare systems and reducing inequalities by evidence based decision making and dissemination of best practice, and innovative technologies and approaches.
Amendment 1357 #
Proposal for a regulation
Annex 1 – Part 3 – point 1 – point 1.3 – paragraph 5
Annex 1 – Part 3 – point 1 – point 1.3 – paragraph 5
Specific activities shall include: understanding the determinants of health (including environmental and climate related factors), improving health promotion and disease prevention; understanding disease and improving diagnosis; developing effective screening programmes and improving the assessment of disease susceptibility; improving surveillance and preparedness; developing better preventive vaccines; using in-silico medicine for improving disease management and prediction; treating disease; transferring knowledge to clinical practice and scalable innovation actions; better use of health data; active ageing, independent and assisted living; addressing infertility disorders; individual empowerment for self-management of health; promotion of integrated care; improving scientific tools and methods to support policy making and regulatory needs; and optimising the efficiency and effectiveness of healthcare systems and reducing inequalities by evidence based decision making and dissemination of best practice, and innovative technologies and approaches.
Amendment 1445 #
Proposal for a regulation
Annex 1 – Part 3 – point 3 – point 3.1 – paragraph 2
Annex 1 – Part 3 – point 3 – point 3.1 – paragraph 2
The Union intends to reduce greenhouse gas emissions by 20 % below 1990 levels by 2020, with an eventual further reduction to 80-95 % by 2050. In addition, renewables should cover 20 % of final energy consumption in 2020 coupled with a 20 % energy efficiency target. Achieving these objectives will require an overhaul of the energy system combining low carbon profile, energy security and affordability, while at the same time reinforcing Europe's economic competitiveness. Europe is currently far from this overall goal. 80 % of the European energy system still relies on fossil fuels, and the sector produces 80 % of all the Union's greenhouse gas emissions. Every year 2.5 % of the Union's Gross Domestic Product (GDP) is spent on energy imports and this is likely to increase. This trend would lead to total dependence on oil and gas imports by 2050, unless new sources are developed in the EU in a sustainable way. Faced with volatile energy prices on the world market, coupled with concerns over security of supply, European industries and consumers are spending an increasing share of their income on energy.
Amendment 1450 #
Proposal for a regulation
Annex 1 – Part 3 – point 3 – point 3.1 – paragraph 3
Annex 1 – Part 3 – point 3 – point 3.1 – paragraph 3
The roadmap to a competitive low-carbon economy in 205027 show, as drafted by the European Commission, assumes that the targeted reductions in greenhouse gas emissions will have to be met largely within the territory of the Union in light of the lack of worldwide agreement on the issue. This would entail reducing CO2 emissions even by over 90 % by 2050 in the power sector, by over 80 % in industry, by at least 60 % in transport and by about 90 % in the residential sector and services.
Amendment 1498 #
Proposal for a regulation
Annex 1 – Part 3 – point 3 – point 3.3 – point b – paragraph 1
Annex 1 – Part 3 – point 3 – point 3.3 – point b – paragraph 1
Activities shall focus on research, development and full scale demonstration - of innovative renewables and, flexible and efficient fossil fuel power plants including carbon capture and storage technologies offering larger scale, lower cost, environmentally safe technologies with higher conversion efficiency, adequate flexibility for back-up power generation and higher availability for different market and operating environments.
Amendment 1510 #
Proposal for a regulation
Annex 1 – Part 3 – point 3 – point 3.3 – point c – paragraph 1
Annex 1 – Part 3 – point 3 – point 3.3 – point c – paragraph 1
Activities shall focus on research, development and full scale demonstration of technologies and value chains to make bio-energy and other alternative fuels more competitive and sustainable, to reduce time to market for hydrogen and fuel cells and to bring new options showing long-term potential to maturity.
Amendment 1512 #
Proposal for a regulation
Annex 1 – Part 3 – point 3 – point 3.3 – point c – paragraph 1 a (new)
Annex 1 – Part 3 – point 3 – point 3.3 – point c – paragraph 1 a (new)
Activities shall also focus on the research, development and full scale demonstration of technologies and/or materials enabling higher flexibility and efficiency of thermal power plants having to cope with the necessity to step in when intermittent renewables are not able to deliver to the system and to ensure grid stability.
Amendment 1714 #
Proposal for a regulation
Annex 1 – Part 3 – point 6.3 – point 6.3.2 – paragraph 1 a (new)
Annex 1 – Part 3 – point 6.3 – point 6.3.2 – paragraph 1 a (new)